ISSN: 1742-5255

Journal Home

Journal Guideline

Expert Opinion on Drug Metabolism and Toxicology Q1 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Opinion on Drug Metabolism and Toxicology is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 100. It has an SJR impact factor of 0,987 and it has a best quartile of Q1. It has an SJR impact factor of 0,987.

Expert Opinion on Drug Metabolism and Toxicology focuses its scope in these topics and keywords: adme, drug, populationbased, pharmacokinetics, pathways, ototoxicity, modelingbioluminescent, mechanisms, luminogenic, problemthe, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q1) Pharmacology (Q1) Toxicology (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Expert Opinion on Drug Metabolism and Toxicology

0,987

SJR Impact factor

100

H Index

87

Total Docs (Last Year)

267

Total Docs (3 years)

7118

Total Refs

1138

Total Cites (3 years)

252

Citable Docs (3 years)

3.84

Cites/Doc (2 years)

81.82

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1

Compare this journals

Aims and Scope

Best articles by citations

Pharmacokinetic interactions between HIV antiretroviral therapy and drugs used to treat opioid dependence

Advances in paediatric pharmacokinetics

Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, in the treatment of type 2 diabetes

An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/ hyperactivity disorder

Evaluation of pharmacokinetic and pharmacodynamic interactions of canagliflozin and teneligliptin in Japanese healthy male volunteers

The usefulness of genotyping cytochrome P450 enzymes in the treatment of depression

The use of hepatotoxic signals to predict the safety of peroxisome proliferator-activated receptor agonists

Tissue-engineered blood vessels as promising tools for testing drug toxicity

Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors

Clinical implications ofCYP3Apolymorphisms

Tadalafil for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Pharmacodynamics of antimicrobials: treatment optimisation

SHOW MORE ARTICLES

Current understanding of pharmacogenetic implications of DNA damaging drugs used in osteosarcoma treatment

Tenofovir alafenamide use in pregnant and lactating women living with HIV

Desloratadine and pseudoephedrine combination therapy as a comprehensive treatment for allergic rhinitis and nasal congestion

Tenofovir disoproxil fumarate for the treatment of HIV infection

The debate on animal ADME studies in drug development: an update

Tocilizumab for treating rheumatoid arthritis: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy

A decade of advances in metabonomics

Current views on the fundamental mechanisms of cytochrome P450 allosterism

Structure-activity relationships of the glucuronidation of flavonoids by human glucuronosyltransferases

A double-blinded, placebo-controlled, multicenter clinical trial ofN-acetylcysteine for preventing amphotericin B-induced nephrotoxicity

Methylnaltrexone bromide: research update of pharmacokinetics following parenteral administration

Finasteride for prostatic disease: an updated and comprehensive review